Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cognition-enhancing drugs.

Literature DB >> 15330974

Cognition-enhancing drugs.

Abstract

New drugs that enhance cognition in cognitively healthy individuals present difficult public policy challenges. While their use is not inherently unethical, steps must be taken to ensure that they are safe, that they are widely available to promote equality of opportunity, and that individuals are free to decide whether or not to use them.

Keywords: Health Care and Public Health; Legal Approach

Mesh：

Substances：
Nootropic Agents

Year: 2004 PMID： 15330974 PMCID： PMC2690227 DOI： 10.1111/j.0887-378X.2004.00319.x

Source DB: PubMed Journal: Milbank Q ISSN： 0887-378X Impact factor: 4.911

18 in total

1. Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine.

Authors: Nancy Jo Wesensten; Gregory Belenky; Mary A Kautz; David R Thorne; Rebecca M Reichardt; Thomas J Balkin
Journal: Psychopharmacology (Berl) Date: 2001-10-19 Impact factor: 4.530

2. The law of above averages: leveling the new genetic enhancement playing field.

Authors: M J Mehlman
Journal: Iowa Law Rev Date: 2000-01

3. Do 'smart' mice feel more pain, or are they just better learners?

Authors: Y Tang; E Shimizu; J Z Tsien
Journal: Nat Neurosci Date: 2001-05 Impact factor: 24.884

4. How will we regulate genetic enhancement?

Authors: M J Mehlman
Journal: Wake Forest Law Rev Date: 1999

Review 5. Emerging ethical issues in neuroscience.

Authors: Martha J Farah
Journal: Nat Neurosci Date: 2002-11 Impact factor: 24.884

6. Viagra: a success story for rationing?

Authors: Rudolf Klein; Heidrun Sturm
Journal: Health Aff (Millwood) Date: 2002 Nov-Dec Impact factor: 6.301

Review 7. Cognitive effects of nicotine.

Authors: A H Rezvani; E D Levin
Journal: Biol Psychiatry Date: 2001-02-01 Impact factor: 13.382

8. A double-blind, placebo-controlled investigation of the efficacy of modafinil for sustaining the alertness and performance of aviators: a helicopter simulator study.

Authors: J A Caldwell; J L Caldwell; N K Smythe; K K Hall
Journal: Psychopharmacology (Berl) Date: 2000-06 Impact factor: 4.530

9. Genetic enhancement of inflammatory pain by forebrain NR2B overexpression.

Authors: F Wei; G D Wang; G A Kerchner; S J Kim; H M Xu; Z F Chen; M Zhuo
Journal: Nat Neurosci Date: 2001-02 Impact factor: 24.884

10. Donepezil and flight simulator performance: effects on retention of complex skills.

Authors: J A Yesavage; M S Mumenthaler; J L Taylor; L Friedman; R O'Hara; J Sheikh; J Tinklenberg; P J Whitehouse
Journal: Neurology Date: 2002-07-09 Impact factor: 9.910

16 in total

Review 1. Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals.

Authors: M Elizabeth Smith; Martha J Farah
Journal: Psychol Bull Date: 2011-09 Impact factor: 17.737

2. The Role of Different Behavioral and Psychosocial Factors in the Context of Pharmaceutical Cognitive Enhancers' Misuse.

Authors: Tina Tomažič; Anita Kovačič Čelofiga
Journal: Healthcare (Basel) Date: 2022-05-24

Review 3. Disagreements with implications: diverging discourses on the ethics of non-medical use of methylphenidate for performance enhancement.

Authors: Cynthia Forlini; Eric Racine
Journal: BMC Med Ethics Date: 2009-07-06 Impact factor: 2.652

10. Performance enhancement in the workplace: why and when healthy individuals should disclose their reliance on pharmaceutical cognitive enhancers.

Authors: Mirko D Garasic; Andrea Lavazza
Journal: Front Syst Neurosci Date: 2015-02-25